ZADITEN L.P. 2 mg, extended-release film-coated tablet 30 tablets
Active ingredients: Ketotifen fumarate, KETOTIFÈNE BASE
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZADITEN L.P. 2 mg, comprimé pelliculé à libération prolongée
- Pharmaceutical form
- comprimé pelliculé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- ALFASIGMA (ITALIE)
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jun 1995
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67926980CIP73369214CIP133400933692148Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUMARATE DE KETOTIFÈNEcomprimé | 2,75 mg · un comprimé | SA |
| KETOTIFÈNE BASEcomprimé | 2 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.